A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents - Trial 2015-004880-35
Access comprehensive clinical trial information for 2015-004880-35 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development Ltd and is currently status unknown. The study focuses on Migraine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2015-004880-35
Trial Details
EU Clinical Trials Register • 2015-004880-35
A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
Study Focus
Sponsor & Location
GlaxoSmithKline Research & Development Ltd
GSK
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Subject is < 30 kg.
ICD-10 Classifications
Migraine
Other migraine
Migraine, unspecified
Complicated migraine
Headache
Data Source
EU Clinical Trials Register
2015-004880-35
Non-Device Trial